Belongs to

• Solid Tumor Oncology Division

Types of Work

["2019"]

[[["Meeting Abstracts",1090],["Journal Articles",996],["Book Sections",38],["Reviews",19],["Conference Papers",16],["Editorials",13],["Guidelines",5],["Books Whole",2],["Miscellaneous",2],["Correspondences",1],["Research Letters",1]]]

[2183]

Popular keywords

• adult
• aged
• article
• controlled study
• female
• human
• lung neoplasms
• major clinical study
• male
• priority journal

Recent Works

1. Characterization and management of ERK inhibitor associated dermatologic adverse events: Analysis from a nonrandomized trial of ulixertinib for advanced cancers

   Journal Article

   Wu, J.; Liu, D.; Offin, M.; Lezcano, C.; Torrisi, J. M.; Brownstein, S.; Hyman, D. M.; Gounder, M. M.; Abida, W.; Drilon, A.; more...
   Investigational New Drugs (2021)

   Fulltext@MSK | Save
2. Any day, split halfway: Flexibility in scheduling high-dose cisplatin - A large retrospective review from a high-volume cancer center

   Journal Article

   Kang, J. J.; Tchekmedyian, V.; Mohammed, N.; Rybkin, A.; Kitpanit, S.; Fan, M.; Wang, H.; Lobaugh, S. M.; Zhang, Z.; Lee, A.; more...
   International Journal of Cancer (2021)

   Fulltext@MSK | Save
3. IgE blockade with omalizumab reduces pruritus related to immune checkpoint inhibitors and anti-HER2 therapies

   Journal Article

   Barrios, D. M.; Phillips, G. S.; Geisler, A. N.; Trelles, S. R.; Markova, A.; Noor, S. J.; Quigley, E. A.; Haliasos, H. C.; Moy, A. P.; Schram, A. M.; more...
   Annals of Oncology (2021)

   Fulltext@MSK | Save